Literature DB >> 9610738

Phenotypic diversity in human fibroblasts from myelometaplasic and non-myelometaplasic hematopoietic tissues.

D Brouty-Boyé1, C Doucet, D Clay, M C Le Bousse-Kerdiles, T J Lampidis, B Azzarone.   

Abstract

Fibroblasts from a variety of tissues interact with and influence the behavior of the cell types they are associated with by producing specific proteins that mediate these interactions. Thus, it is not surprising that fibroblasts have been shown to differ phenotypically and functionally depending on the tissue they are isolated from and its physiologic state. To study fibroblasts of hematopoietic tissues, cultures were established from human normal bone marrow (BM), and from non-myelometaplasic (NS) and myelometaplasic spleen (MMS) tissues and analyzed for phenotypic characteristics. The results are summarized as follows: (1) cytoskeletal elements: virtually all the MMS fibroblasts were stained positively for alpha-sm-actin while only a small fraction of BM and of NS fibroblasts were positive for this antigen; (2) extracellular matrix elements: MMS fibroblasts stained positively for ED-B fibronectin and tenascin while the other 2 fibroblast cell types did not; (3) cell surface molecules: NS and MMS fibroblasts expressed significantly higher levels of ICAM-1, VLA-4 and CD9 than BM fibroblasts. Moreover, MMS fibroblasts showed a higher expression of ICAM-1 and VLA-4 than NS fibroblasts; and (4) cytokines: IL-II, RANTES and MIP-1alpha were produced in higher amounts by BM than by NS fibroblasts. Conversely, production of GM-CSF, SCF, M-CSF and MCP-1alpha was elevated in NS compared with BM fibroblasts. The production of these cytokines was generally reduced in MMS cells. Overall, our results demonstrate that phenotypic characteristics can be identified to distinguish fibroblasts from normal and pathologic hematopoietic tissues. Such phenotypic characteristics suggest functional differences of each type of fibroblast in their influence on the blood cells with which they are associated.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9610738     DOI: 10.1002/(sici)1097-0215(19980529)76:5<767::aid-ijc24>3.0.co;2-#

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

1.  Importance of stromal determinants in the generation of dendritic and natural killer cells in the human spleen.

Authors:  D Briard; B Azzarone; D Brouty-Boyé
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

Review 2.  Rational therapeutic options for patients with myeloproliferative neoplasms.

Authors:  Ronald Hoffman
Journal:  Trans Am Clin Climatol Assoc       Date:  2011

3.  Long-term persistence of limited HTLV-I Tax-specific cytotoxic T cell clones in a patient with adult T cell leukemia/lymphoma after allogeneic stem cell transplantation.

Authors:  Yukie Tanaka; Hideki Nakasone; Rie Yamazaki; Hidenori Wada; Yuko Ishihara; Koji Kawamura; Kana Sakamoto; Masahiro Ashizawa; Tomohito Machishima; Miki Sato; Kiriko Terasako; Shun-ichi Kimura; Misato Kikuchi; Shinya Okuda; Shinichi Kako; Junya Kanda; Aki Tanihara; Junji Nishida; Yoshinobu Kanda
Journal:  J Clin Immunol       Date:  2012-07-05       Impact factor: 8.317

Review 4.  Myelofibrosis: pathogenesis of myelofibrosis with myeloid metaplasia. French INSERM Research Network on Myelofibrosis with Myeloid Metaplasia.

Authors:  M C Le Bousse-Kerdilès; M C Martyré
Journal:  Springer Semin Immunopathol       Date:  1999

5.  Polarized subsets of human T-helper cells induce distinct patterns of chemokine production by normal and systemic sclerosis dermal fibroblasts.

Authors:  Carlo Chizzolini; Yann Parel; Agneta Scheja; Jean-Michel Dayer
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

Review 6.  Immune interactions in hepatic fibrosis.

Authors:  Andrew P Holt; Mike Salmon; Christopher D Buckley; David H Adams
Journal:  Clin Liver Dis       Date:  2008-11       Impact factor: 6.126

7.  Detection of a functional hybrid receptor gammac/GM-CSFRbeta in human hematopoietic CD34+ cells.

Authors:  J Giron-Michel; M Fogli; A Gaggero; S Ferrini; A Caignard; D Brouty-Boye; S Baouz; M-C Le Bousse-Kerdiles; B Peault; M van Dijk; S Bulfone-Paus; D Durali; S Chouaib; B Azzarone
Journal:  J Exp Med       Date:  2003-03-17       Impact factor: 14.307

Review 8.  Inflammation as a Keystone of Bone Marrow Stroma Alterations in Primary Myelofibrosis.

Authors:  Christophe Desterke; Christophe Martinaud; Nadira Ruzehaji; Marie-Caroline Le Bousse-Kerdilès
Journal:  Mediators Inflamm       Date:  2015-11-12       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.